Vitamins may have larger role in halting brain decline: Review

By Will Chu

- Last updated on GMT

The brain has a high metabolic rate; therefore, oxidative stress and inflammation are common in ageing neural tissue. ©iStock/Attila Barabas
The brain has a high metabolic rate; therefore, oxidative stress and inflammation are common in ageing neural tissue. ©iStock/Attila Barabas
The role for folate and related B vitamins in slowing down the decline in brain function is very much underestimated as is their role in age-related depression, a review claims.

Findings point towards members of the B vitamin family as equally efficacious as specific nutrients, including omega-3 polyunsaturated fatty acids and polyphenols.

The team believe that together these nutrients may form effective nutrition strategies that could reduce the risk of cognitive and mental disorders and improve quality of life for the elderly.

An estimated 46.8 million people are living with dementia worldwide with this figure predicted to double in the next 20 years.

In addition, depression is a leading cause of disability, currently costing approximately £7.5 billion annually in England alone with an increase predicted by 67% by 2026.

The role of nutrients is often underestimated but never fully discounted as studies have shown much inconsistency in vitamin intake in promoting better brain health.

Trial differences

older_consumer_pills_vitamins_supplements_istock
specific nutrients, including n-3 polyunsaturated fatty acids, polyphenols and B vitamins may play a role in slowing down age-related cognitive decline. ©iStock

The review, carried out by Ulster University in the UK, concluded that folate and vitamin B12 may have roles in the longer term management of this condition.

“If the findings of studies described in this review, which show promise in relation to B vitamins, omega-3 polyunsaturated fatty acids and polyphenols, are confirmed, a public health strategy to improve status of these key nutrients may help to achieve better cognitive and mental health in ageing.”

The team identified the inconsistencies of vitamin experiments as possibly stemming from uncertain methodology and study design.

“It is clear that further well-designed RCTs are needed, especially those targeting participants with low B vitamin status as they are likely to benefit the most from increasing B vitamin concentrations to achieve better cognitive health in ageing,”​ the study said.

The role of B vitamins in depressive disorders has not received as much interest as in cognitive function, said the study authors as they also cited methodological differences among studies for varying results.

The team recommended that future studies incorporating imaging techniques would offer a robust basis for confirming effective nutrition interventions.

This could reduce the risk of cognitive and mental decline in ageing and the related burden on health services.

Source: Nutrition Bulletin

Published online ahead of print: DOI: 10.1111/nbu.12250

“Current evidence linking nutrition with brain health in ageing”

Authors: K. Moore, M. O'Shea, C. F. Hughes, L. Hoey, M. Ward, H. McNulty

Related news

Show more

Related products

show more

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 27-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

Research for Restorative Sleep: Levagen®+

Research for Restorative Sleep: Levagen®+

Content provided by Gencor | 09-Sep-2024 | White Paper

Levagen®+ is Gencor's branded Palmitoylethanolamide (PEA), an endogenous fatty acid amide naturally found in every cell of the body.

From Biofarma a clinically tested vaginal protection

From Biofarma a clinically tested vaginal protection

Content provided by Biofarma Group | 05-Sep-2024 | Product Brochure

Bacterial vaginosis is considered the most common cause of vaginal infection among pregnant and non-pregnant women. In this scenario, the oral intake of...

Related suppliers

Follow us

Products

View more

Webinars